REFERENCES
- Baum O, Da Silva-Azevedo L, Willerding G, Wockel A, Planitzer G, Gossrau R, Pries A R, Zakrzewicz A. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol 2004; 287: H2300–H2308, [PUBMED], [INFOTRIEVE], [CSA]
- Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner J M. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114–1123, [PUBMED], [INFOTRIEVE], [CSA]
- Critical Limb Ischemia, A Branchereau, M Jacobs. Futura, Armonk 1999
- Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post M J, Wahlberg E, Leboulch P, Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9: 604–613, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carmeli E, Moas M, Reznick A Z, Coleman R. Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 2004; 29: 191–197, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Comerota A J, Throm R C, Miller K A, Henry T, Chronos N, Laird J, Sequeira R, Kent C K, Bacchetta M, Goldman C, Salenius J P, Schmieder F A, Pilsudski R. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 2002; 35: 930–936, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Conway E M, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507–521, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Couffinhal T, Silver M, Zheng L P, Kearney M, Witzenbichler B, Isner J M. Mouse model of angiogenesis. Am J Pathol 1998; 152: 1667–1679, [PUBMED], [INFOTRIEVE]
- Da Silva-Azevedo L, Baum O, Zakrzewicz A, Pries A. Vascular endothelial growth factor is expressed in endothelial cells isolated from skeletal muscles of nitric oxide synthase knockout mice during prazosin-induced angiogenesis. Biochem Biophys Res Commun 2002; 297: 1270–1276, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dawson D L, Hagino R T. Critical limb ischemia. Curr Treat Options Cardiovasc Med 2001; 3: 237–249, [PUBMED], [INFOTRIEVE]
- Djonov V, Baum O, Burri P. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 2003; 314: 107–117, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Djonov V, Schmid M, Tschanz S A, Burri P H. Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 2000; 86: 286–292, [PUBMED], [INFOTRIEVE]
- Donnelly R, Yeung J M. Therapeutic angiogenesis: a step forward in intermittent claudication. Lancet 2002; 359: 2048–2050, [PUBMED], [INFOTRIEVE], [CROSSREF]
- European working group on critical leg ischemia. Second European consensus document on chronic critical leg ischemia. Circulation 1991; 84(Suppl IV)IV1–IV26
- Flück M, Gustafsson T. VEGF protein in human ischemic skeletal muscle. Am J Pathol 2003; 163: 2636–2637
- Gerhardt H, Betsholtz C. Endothelial–pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314: 15–23, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gloe T, Sohn H Y, Meininger G A, Pohl U. Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3. J Biol Chem 2002; 277: 23453–23458, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gustafsson T, Kraus W E. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci 2001; 1: D75–D89
- Hansen-Smith F, Egginton S, Zhou A L, Hudlicka O. Growth of arterioles precedes that of capillaries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 2001; 62: 1–14, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 2003; 10: 83–97, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lederman R J, Mendelsohn F O, Anderson R D, Saucedo J F, Tenaglia A N, Hermiller J B, Hillegass W B, Rocha-Singh K, Moon T E, Whitehouse M J, Annex B H. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002; 359: 2053–2058, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lindner V, Reidy M A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739–3743, [PUBMED], [INFOTRIEVE], [CSA]
- Lloyd-Jones D M, Bloch K D. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996; 47: 365–375, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002; 90: 966–973, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McMillan D E. Diabetic angiopathy-its lessons in vascular physiology. Am Heart J 1978; 96: 401–406, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nehls V, Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 1991; 113: 147–154, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Palmer-Kazen U, Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium 2003; 10: 225–232, [PUBMED], [INFOTRIEVE], [CSA]
- Palmer-Kazen U, Wariaro D, Luo F, Wahlberg E. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia. J Vasc Surg 2004; 39: 621–628, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peirce S M, Skalak T C. Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 2003; 10: 99–111, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rissanen T T, Vajanto I, Hiltunen M O, Rutanen J, Kettunen M I, Niemi M, Leppanen P, Turunen M P, Markkanen J E, Arve K, Alhava E, Kauppinen R A, Yla-Herttuala S. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 2002; 160: 1393–1403, [PUBMED], [INFOTRIEVE]
- Stroka D M, Burkhardt T, Desbaillets I, Wenger R H, Neil D A, Bauer C, Gassmann M, Candinas D. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. Faseb J 2001; 15: 2445–2453, [PUBMED], [INFOTRIEVE], [CSA]
- Sullivan C J, Doetschman T, Hoying J B. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 2002; 93: 2009–2017, [PUBMED], [INFOTRIEVE]
- Tsilibary E C. Microvascular basement membranes in diabetes mellitus. J Pathol 2003; 200: 537–546, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tuomisto T T, Rissanen T T, Vajanto I, Korkeela A, Rutanen J, Yla-Herttuala S. HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array. Atherosclerosis 2004; 174: 111–120, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Van Gieson E J, Murfee W L, Skalak T C, Price R J. Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ Res 2003; 92: 929–936, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vincent K A, Shyu K G, Luo Y, Magner M, Tio R A, Jiang C, Goldberg M A, Akita G Y, Gregory R J, Isner J M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000; 102: 2255–2261, [PUBMED], [INFOTRIEVE]
- Walgenbach K J, Gratas C, Shestak K C, Becker D. Ischaemia-induced expression of bFGF in normal skeletal muscle: a potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1995; 1: 453–459, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu H M, Yuan Y, McCarthy M, Granger H J. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol 1996; 271: H1087–H1093, [PUBMED], [INFOTRIEVE]
- Yancopoulos G D, Davis S, Gale N W, Rudge J S, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694–701, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]